title: [Omeprazole prevention of the recurrence of peptic ulcer: the efficacy of treatment with 20 mg on alternate days].
abstract: Omeprazole, 20 mg every second day, in prevention of duodenal ulcer relapse has been tested. 15 patients with peptic ulcer, which was endoscopically proved and then healed, underwent the treatment. No matter of ulcer original seat as well as antacid drug previously employed, recurrences were not seen after a 6 months period, while clinical symptoms and possible adverse reactions appeared to be very slight. The proposed regimen of omeprazole seems to be cost-saving and worth proving.
authors.affiliation: Cattedra di Patologia Speciale Chirurgica, Istituto di Clinica Chirurgica I, Università, Padova.
authors.forename: P
authors.initials: P
authors.lastname: Petrin
authors.forename: V
authors.initials: V
authors.lastname: Costantino
authors.forename: A
authors.initials: A
authors.lastname: Canton
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004341:Drug Evaluation; D005260:Female; D005755:Gastrins / Q000097:blood / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000008:administration & dosage* / Q000009:adverse effects; D010437:Peptic Ulcer / Q000097:blood / Q000517:prevention & control*; D012008:Recurrence; D013997:Time Factors
chemical_list: D005755:Gastrins; D009853:Omeprazole